Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
Quick Stats
Jan 30, 202647.0
AI Score
HOLD0.4
Volume Ratio
Feb 19, 2026
Next Earnings
15
+ve Days (30d)
8
-ve Days (30d)
DVAX Stock Summary
Last updated Jan 30, 2026
DVAX is currently trading at $15.485, positioned above its 200-day moving average of $11.07, indicating a long-term uptrend. The stock has a 52-week range of $9.2 to $15.73.
Technical Analysis: The 50-day moving average stands at $13.26, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 76.175, suggesting the stock is in overbought territory (bullish but caution advised).
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.001, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates DVAX at 47.0/100 with a HOLD recommendation.
DVAX (Dynavax Technologies Corporation) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 76.175 |
| CMF (20) | -0.001 |
| ROC (10) | -0.864 |
| ADX (14) | 59.727 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.608 |
| AROONOSC (14) | 7.143 |
| WILLAMS %R (14) | -94.231 |
| MFI (14) | 62.822 |
DVAX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
DVAX Price vs Max Options Open Interest
DVAX Max Change In Options Open Interest
DVAX Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
DVAX Daily Out of Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
DVAX Daily In the Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
DVAX Most Active Options by Volume(near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Dynavax Technologies Corporation is above both 50 Day and 200 Day SMA which is considered Bullish.
DVAX Moving Averages Analysis
Dynavax Technologies Corporation has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
Dynavax Technologies Corporation has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
DVAX (Dynavax Technologies Corporation) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 15.56 |
| 20 | 15.53 |
| 30 | 14.75 |
| 50 | 13.26 |
| 100 | 11.71 |
| 200 | 11.07 |
DVAX Fundamental Analysis
| P/E (Forward) | 29.2398 |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.8 billion |
| Earnings/Share ($) | -0.37 |
| Net Proft Margin (%) | -0.1313 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.5 |
| EPS Estimate Next Year ($) | 0.33 |
| WallStreet Target Price ($) | 22 |
| Most Recent Quarter |